Cargando…

Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead

The development of immune checkpoint inhibitors, the monoclonal antibodies that modulate the interaction between immune checkpoint molecules or their ligands on the immune cells or tumor tissue has revolutionized cancer treatment. While there are various studies proving their efficacy in hematologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aru, Basak, Soltani, Mojdeh, Pehlivanoglu, Cemil, Gürlü, Ege, Ganjalikhani-Hakemi, Mazdak, Yanikkaya Demirel, Gülderen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829140/ https://www.ncbi.nlm.nih.gov/pubmed/35155232 http://dx.doi.org/10.3389/fonc.2022.789728

Ejemplares similares

A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
por: Aru, Başak, et al.
Publicado: (2023)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2022)

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
por: Soltani, Mojdeh, et al.
Publicado: (2021)

Testosterone Propionate Promotes Proliferation and Viability of Bone Marrow Mesenchymal Stem Cells while Preserving Their Characteristics and Inducing Their Anti-Cancer Efficacy
por: Aru, Başak, et al.
Publicado: (2023)

Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy
por: Aru, Başak, et al.
Publicado: (2021)

TIM-3 in Leukemia; Immune Response and Beyond
por: Rezaei, Mahnaz, et al.
Publicado: (2021)

A Translational Study of a Silicon Phthalocyanine Substituted with a Histone Deacetylase Inhibitor for Photodynamic Therapy
por: Aru, Başak, et al.
Publicado: (2020)

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
por: Soltani, Mojdeh, et al.
Publicado: (2023)

Results of the Hematology Laboratory Survey: What has Changed in Eight Years?
por: Kozanoğlu, İlknur, et al.
Publicado: (2018)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Shapoorian, Hooriyeh, et al.
Publicado: (2021)

Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality
por: Zalpoor, Hamidreza, et al.
Publicado: (2022)

The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020)

siRNA Delivery Improvement by Co-formulation of Different Modified Polymers in Erythroleukemic Cell Line K562
por: Ganjalikhani hakemi, Mazdak, et al.
Publicado: (2013)

A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers
por: Dehbashi, Moein, et al.
Publicado: (2021)

Nicotinamide Effects Oxidative Burst Activity of Neutrophils in Patients with Poorly Controlled Type 2 Diabetes Mellitus
por: Osar, Zeynep, et al.
Publicado: (2004)

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet's Disease
por: Pekiner, Filiz Namdar, et al.
Publicado: (2013)

TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
por: Rezaei, Mahnaz, et al.
Publicado: (2023)

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
por: Bakhtiari, Tahereh, et al.
Publicado: (2023)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency
por: Yazdani, Reza, et al.
Publicado: (2014)

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
por: Swart, Maarten, et al.
Publicado: (2016)

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
por: Lei, Yanna, et al.
Publicado: (2021)

A preliminary study of tracking B-cell kinetics in patients with lung transplantation by monitoring kappa-deleting recombination excision circles
por: Akbulut, Zeynep, et al.
Publicado: (2022)

Outcome of Corneal Collagen Cross-Linking in Keratoconus: Introducing the Predictive Factors
por: Peyman, Alireza, et al.
Publicado: (2020)

Liver Resection Promotes (Regulates) Proinflammatory Cytokines in Patients with Hepatocellular Carcinoma
por: Fathi, Farshid, et al.
Publicado: (2021)

Designing and generating a single-chain fragment variable (scFv) antibody against IL2Rα (CD25): An in silico and in vitro study
por: Navabi, Parnian, et al.
Publicado: (2021)

Flow Cytometric Analyses of Lymphocyte Markers in Immune Oncology: A Comprehensive Guidance for Validation Practice According to Laws and Standards
por: Lambert, Claude, et al.
Publicado: (2020)

RORC2 Gene Silencing in Human Th17 Cells by siRNA: Design and Evaluation of Highly Efficient siRNA
por: Hakemi, Mazdak Ganjalikhani, et al.
Publicado: (2013)

Evaluation of the T helper 17 cell specific genes and the innate lymphoid cells counts in the peripheral blood of patients with the common variable immunodeficiency
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2014)

Positive and Negative Regulation of Th17 Cell Differentiation: Evaluating The Impact of RORC2
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2014)

Optimization of In Vitro Expansion and Activation of Human Natural Killer Cells against Breast Cancer Cell Line
por: Peighambarzadeh, Farzaneh, et al.
Publicado: (2020)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
por: Russell, Bonnie L., et al.
Publicado: (2021)

Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
por: Wu, Yaoqiang, et al.
Publicado: (2022)

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
por: Scott, Susan C., et al.
Publicado: (2022)

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
por: Lee, Junghwa, et al.
Publicado: (2023)

Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights
por: Zalpoor, Hamidreza, et al.
Publicado: (2022)

Genistein potentiates the effect of 17-beta estradiol on human hepatocellular carcinoma cell line
por: Kavoosi, Fraidoon, et al.
Publicado: (2016)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mb6tjbee4vu91odr3thnhtjhob